Selumetinib Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 10mg, 25mg
Reference Brands: Koselugo (USA)
Category: Neurology
Selumetinib is a selective inhibitor of the enzymes MEK1 and MEK2, which are part of a signalling pathway involved in cell growth and division. By blocking MEK1/2, selumetinib helps reduce abnormal growth of nerve-sheath tumors (plexiform neurofibromas) in people with genetic disorder Neurofibromatosis type 1 (NF1). Koselugo is indicated for patients (children and now adults) with symptomatic, inoperable plexiform neurofibromas — helping shrink tumor volume or slow growth when surgical removal is not feasible. Selumetinib is available in Capsules and strengths such as 10mg, 25mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Selumetinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Selumetinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Selumetinib is used to treat neurofibromatosis type 1 (NF1) in children with inoperable plexiform neurofibromas. It works by inhibiting the MEK1 and MEK2 enzymes in the RAS/MAPK pathway, which helps reduce tumor growth.
Selumetinib is made from the active pharmaceutical ingredient selumetinib hydrochloride, a small-molecule MEK inhibitor.
The trade name is Koselugo.
Koselugo is manufactured by AstraZeneca.
The generic name is selumetinib hydrochloride.
The primary brand name is Koselugo.
It is manufactured in approved pharmaceutical facilities in Europe and the USA, depending on regulatory approvals.
Related Products
Donepezil Hydrochloride
Strength:
5 mg, 10 mg, 23 mg
Form: Tablets
Reference Brands: Aricept (USA/EU)
View Details
Acetazolamide Sodium
Strength:
125 mg, 250 mg, 500 mg,
Form: Tablets/ capsules/ Injectable
Reference Brands: Diamox (USA)
View Details
Rimegepant
Strength:
75 mg
Form: Tablets
Reference Brands: Nurtec ODT (USA), Vydura (EU)
View Details
Pimavanserin
Strength:
17 mg, 34 mg, 51 mg
Form: Tablets
Reference Brands: Nuplazid (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
